Publicaciones
-
Alaña L, Sesé M, Cánovas V, Punyal Y, Fernández Y, Abasolo I, de Torres I, Ruiz-Herguido C, Espinosa L, Bigas A, Y Cajal SR, Fernández PL, Serras F, Corominas M, Thomson TM and Paciucci R.
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
MOLECULAR CANCER . 13: 74-74. Nº de citas: 26
-
Nimmo R, Ciau-Uitz A, Ruiz-Herguido C, Soneji S, Bigas A, Patient R and Enver T.
MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny.
DEV CELL . 26(3): 237-249. Nº de citas: 60
-
Farrés J, Martín-Caballero J, Martínez C, Lozano JJ, Llacuna L, Ampurdanés C, Ruiz-Herguido C, Dantzer F, Schreiber V, Villunger A, Bigas A and Yélamos J.
Parp-2 is required to maintain hematopoiesis following sublethal ?-irradiation in mice.
Blood . 122(1): 44-54. Nº de citas: 96
-
Ruiz-Herguido C, Guiu J, D'Altri T, Inglés-Esteve J, Dzierzak E, Espinosa L and Bigas A.
Hematopoietic stem cell development requires transient Wnt/ß-catenin activity.
JOURNAL OF EXPERIMENTAL MEDICINE . 209(8): 1457-1468. Nº de citas: 95
-
Inglés-Esteve J, Morales M, Dalmases A, Garcia-Carbonell R, Jené-Sanz A, López-Bigas N, Iglesias M, Ruiz-Herguido C, Rovira A, Rojo F, Albanell J, Gomis RR, Bigas A and Espinosa L.
Inhibition of specific NF-?B activity contributes to the tumor suppressor function of 14-3-3s in breast cancer.
PLoS One . 7(5): . Nº de citas: 30
-
Robert-Moreno A, Guiu J, Ruiz-Herguido C, López ME, Inglés-Esteve J, Riera L, Tipping A, Enver T, Dzierzak E, Gridley T, Espinosa L and Bigas A.
Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1.
EMBO JOURNAL . 27(13): 1886-1895. Nº de citas: 156